Literature DB >> 35997928

De Novo Somatic Mosaicism of CYBB Caused by Intronic LINE-1 Element Insertion Resulting in Chronic Granulomatous Disease.

Lang Yu1,2,3, Wenhui Li1,2,3, Ge Lv1,2,3, Gan Sun1,2,3, Lu Yang1,2,3, Junjie Chen1,2,3, Lina Zhou1,2,3, Yuan Ding1,2,3, Zhiyong Zhang1,2,3,4, Xuemei Tang1,2,3,4, Yunfei An1,2,3,4, Xiaodong Zhao5,6,7.   

Abstract

Chronic granulomatosis disease (CGD) is a rare inborn error of immunity, characterized by phagocytic respiratory outbreak dysfunction. Mutations causing CGD occur in CYBB on the X chromosome and in the autosomal genes CYBA, NCF1, NCF2, NCF4, RAC2, and CYBC1. Nevertheless, some patients are clinically diagnosed with CGD, due to abnormal respiratory outbursts, while the pathogenic gene mutation is unidentified. Here, we report a patient with CGD who first presented with Bacillus Calmette-Guérin disease and had recurrent pneumonia. He was diagnosed with CGD by nitro blue tetrazolium and respiratory burst tests. Detailed assessment of neutrophil activity revealed that patient neutrophils were almost entirely nonfunctional. Sanger sequencing detected a 6-kb insertion of a LINE-1 transposable element in the third intron of CYBB, leading to abnormal splicing and pseudoexon insertion, as well as introduction of a premature termination codon, resulting in predicted protein truncation. Clonal analysis demonstrated that the patient had somatic mosaicism, and the phagocytes were almost all variant CYBB, while the mosaicism rate of PBMC was about 65%. Finally, deep RNA sequencing and gp91phox expression analysis confirmed the pathogenicity of the mutation. In conclusion, we demonstrate that insertion of a LINE-1 transposon in a CYBB intron was responsible for CGD in our patient. Intron LINE-1 transposon element insertion should be examined in CGD patients without any known disease-causing gene mutation, in addition to identification of new genes.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CYBB; LINE-1; chronic granulomatous disease; de novo; insertion; somatic mosaicism

Year:  2022        PMID: 35997928     DOI: 10.1007/s10875-022-01347-w

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.542


  35 in total

1.  Initial sequencing and analysis of the human genome.

Authors:  E S Lander; L M Linton; B Birren; C Nusbaum; M C Zody; J Baldwin; K Devon; K Dewar; M Doyle; W FitzHugh; R Funke; D Gage; K Harris; A Heaford; J Howland; L Kann; J Lehoczky; R LeVine; P McEwan; K McKernan; J Meldrim; J P Mesirov; C Miranda; W Morris; J Naylor; C Raymond; M Rosetti; R Santos; A Sheridan; C Sougnez; Y Stange-Thomann; N Stojanovic; A Subramanian; D Wyman; J Rogers; J Sulston; R Ainscough; S Beck; D Bentley; J Burton; C Clee; N Carter; A Coulson; R Deadman; P Deloukas; A Dunham; I Dunham; R Durbin; L French; D Grafham; S Gregory; T Hubbard; S Humphray; A Hunt; M Jones; C Lloyd; A McMurray; L Matthews; S Mercer; S Milne; J C Mullikin; A Mungall; R Plumb; M Ross; R Shownkeen; S Sims; R H Waterston; R K Wilson; L W Hillier; J D McPherson; M A Marra; E R Mardis; L A Fulton; A T Chinwalla; K H Pepin; W R Gish; S L Chissoe; M C Wendl; K D Delehaunty; T L Miner; A Delehaunty; J B Kramer; L L Cook; R S Fulton; D L Johnson; P J Minx; S W Clifton; T Hawkins; E Branscomb; P Predki; P Richardson; S Wenning; T Slezak; N Doggett; J F Cheng; A Olsen; S Lucas; C Elkin; E Uberbacher; M Frazier; R A Gibbs; D M Muzny; S E Scherer; J B Bouck; E J Sodergren; K C Worley; C M Rives; J H Gorrell; M L Metzker; S L Naylor; R S Kucherlapati; D L Nelson; G M Weinstock; Y Sakaki; A Fujiyama; M Hattori; T Yada; A Toyoda; T Itoh; C Kawagoe; H Watanabe; Y Totoki; T Taylor; J Weissenbach; R Heilig; W Saurin; F Artiguenave; P Brottier; T Bruls; E Pelletier; C Robert; P Wincker; D R Smith; L Doucette-Stamm; M Rubenfield; K Weinstock; H M Lee; J Dubois; A Rosenthal; M Platzer; G Nyakatura; S Taudien; A Rump; H Yang; J Yu; J Wang; G Huang; J Gu; L Hood; L Rowen; A Madan; S Qin; R W Davis; N A Federspiel; A P Abola; M J Proctor; R M Myers; J Schmutz; M Dickson; J Grimwood; D R Cox; M V Olson; R Kaul; C Raymond; N Shimizu; K Kawasaki; S Minoshima; G A Evans; M Athanasiou; R Schultz; B A Roe; F Chen; H Pan; J Ramser; H Lehrach; R Reinhardt; W R McCombie; M de la Bastide; N Dedhia; H Blöcker; K Hornischer; G Nordsiek; R Agarwala; L Aravind; J A Bailey; A Bateman; S Batzoglou; E Birney; P Bork; D G Brown; C B Burge; L Cerutti; H C Chen; D Church; M Clamp; R R Copley; T Doerks; S R Eddy; E E Eichler; T S Furey; J Galagan; J G Gilbert; C Harmon; Y Hayashizaki; D Haussler; H Hermjakob; K Hokamp; W Jang; L S Johnson; T A Jones; S Kasif; A Kaspryzk; S Kennedy; W J Kent; P Kitts; E V Koonin; I Korf; D Kulp; D Lancet; T M Lowe; A McLysaght; T Mikkelsen; J V Moran; N Mulder; V J Pollara; C P Ponting; G Schuler; J Schultz; G Slater; A F Smit; E Stupka; J Szustakowki; D Thierry-Mieg; J Thierry-Mieg; L Wagner; J Wallis; R Wheeler; A Williams; Y I Wolf; K H Wolfe; S P Yang; R F Yeh; F Collins; M S Guyer; J Peterson; A Felsenfeld; K A Wetterstrand; A Patrinos; M J Morgan; P de Jong; J J Catanese; K Osoegawa; H Shizuya; S Choi; Y J Chen; J Szustakowki
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

Review 2.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

3.  Clinical and Molecular Features of Chronic Granulomatous Disease in Mainland China and a XL-CGD Female Infant Patient After Prenatal Diagnosis.

Authors:  Shiyu Wang; Tao Wang; Qingqing Xiang; Min Xiao; Yao Cao; Huan Xu; Shujuan Li; Wen Tian; Xiaodong Zhao; Xuemei Tang; Liping Jiang
Journal:  J Clin Immunol       Date:  2019-08-27       Impact factor: 8.317

4.  Human l1 retrotransposition is associated with genetic instability in vivo.

Authors:  David E Symer; Carla Connelly; Suzanne T Szak; Emerita M Caputo; Gregory J Cost; Giovanni Parmigiani; Jef D Boeke
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

Review 5.  The impact of retrotransposons on human genome evolution.

Authors:  Richard Cordaux; Mark A Batzer
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

Review 6.  Inflammatory manifestations in chronic granulomatous disease (CGD).

Authors:  S D Rosenzweig
Journal:  J Clin Immunol       Date:  2008-01-12       Impact factor: 8.317

7.  Chronic Granulomatous Disease-Like Presentation of a Child with Autosomal Recessive PKCδ Deficiency.

Authors:  Anna-Lena Neehus; Karen Tuano; Tom Le Voyer; Sarada L Nandiwada; Kruthi Murthy; Anne Puel; Jean-Laurent Casanova; Javier Chinen; Jacinta Bustamante
Journal:  J Clin Immunol       Date:  2022-05-18       Impact factor: 8.542

Review 8.  Chronic Granulomatous Disease: a Comprehensive Review.

Authors:  Hsin-Hui Yu; Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2021-10       Impact factor: 8.667

9.  A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease.

Authors:  Gudny A Arnadottir; Gudmundur L Norddahl; Steinunn Gudmundsdottir; Arna B Agustsdottir; Snaevar Sigurdsson; Brynjar O Jensson; Kristbjorg Bjarnadottir; Fannar Theodors; Stefania Benonisdottir; Erna V Ivarsdottir; Asmundur Oddsson; Ragnar P Kristjansson; Gerald Sulem; Kristjan F Alexandersson; Thorhildur Juliusdottir; Kjartan R Gudmundsson; Jona Saemundsdottir; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Sigurdsson; Paolo Manzanillo; Sigurjon A Gudjonsson; Gudmundur A Thorisson; Olafur Th Magnusson; Gisli Masson; Kjartan B Orvar; Hilma Holm; Sigurdur Bjornsson; Reynir Arngrimsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Ingileif Jonsdottir; Asgeir Haraldsson; Patrick Sulem; Kari Stefansson
Journal:  Nat Commun       Date:  2018-10-25       Impact factor: 14.919

Review 10.  Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).

Authors:  Dirk Roos; Karin van Leeuwen; Amy P Hsu; Debra Long Priel; Amber Begtrup; Rhonda Brandon; Marie José Stasia; Faris Ghalib Bakri; Nezihe Köker; M Yavuz Köker; Manisha Madkaika; Martin de Boer; Maria Bravo Garcia-Morato; Juan Luis Valdivieso Shephard; Joachim Roesler; Hirokazu Kanegane; Toshinao Kawai; Gigliola Di Matteo; Mohammad Shahrooei; Jacinta Bustamante; Amit Rawat; Pandiarajan Vignesh; Esmaeil Mortaz; Abbas Fayezi; Deniz Cagdas; Ilhan Tezcan; Maleewan Kitcharoensakkul; Mary C Dinauer; Isabelle Meyts; Baruch Wolach; Antonio Condino-Neto; Christa S Zerbe; Steven M Holland; Harry L Malech; John I Gallin; Douglas B Kuhns
Journal:  Blood Cells Mol Dis       Date:  2021-06-02       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.